Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 3 |
2003 | 1 |
2004 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors.
Crit Rev Oncol Hematol. 2001 Jun;38(3):177-92. doi: 10.1016/s1040-8428(01)00103-2.
Crit Rev Oncol Hematol. 2001.
PMID: 11369253
Review.
Immunotherapy of renal cell carcinoma by intratumoral administration of an IL-2 cDNA/DMRIE/DOPE lipid complex.
Daniels GA, Galanis E.
Daniels GA, et al.
Curr Opin Mol Ther. 2001 Feb;3(1):70-6.
Curr Opin Mol Ther. 2001.
PMID: 11249734
Review.
Item in Clipboard
Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ.
Galanis E, et al.
Hum Gene Ther. 2001 May 1;12(7):811-21. doi: 10.1089/104303401750148766.
Hum Gene Ther. 2001.
PMID: 11339897
Item in Clipboard
Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
Johnson KJ, Peng KW, Allen C, Russell SJ, Galanis E.
Johnson KJ, et al.
Gene Ther. 2003 May;10(9):725-32. doi: 10.1038/sj.gt.3301951.
Gene Ther. 2003.
PMID: 12704411
Item in Clipboard
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E.
Allen C, et al.
J Gene Med. 2004 Nov;6(11):1216-27. doi: 10.1002/jgm.616.
J Gene Med. 2004.
PMID: 15459967
Item in Clipboard
Cite
Cite